Δ8,9-Dehydro Estrone 3-Sulfate Sodium Salt (CAS 61612-83-7)

Δ8,9-Dehydro Estrone 3-Sulfate Sodium Salt, an intermediate compound in the synthesis of estrone and estradiol, serves as a significant biomarker for the diagnosis of adrenal and ovarian tumors. It also plays a role in monitoring the effectiveness of hormone replacement therapy. Widely employed in scientific research, Δ8,9-Dehydro Estrone 3-Sulfate Sodium Salt acts as a biomarker for adrenal and ovarian tumor diagnosis and hormone replacement therapy monitoring. Additionally, it has been extensively studied to unravel the mechanisms of estrogen action and its impact on fertility, bone metabolism, and cardiovascular health. Its biochemical and physiological effects include the regulation of lipid, carbohydrate, and protein metabolism, as well as its involvement in fertility, bone metabolism, cardiovascular health, and its anti-inflammatory and antioxidant properties. Serving as a precursor, Δ8,9-Dehydro Estrone 3-Sulfate Sodium Salt is enzymatically converted into estrone and estradiol, two vital endogenous estrogens, which then act on target tissues to regulate various physiological processes.